Computational Pathology Market Size, Trends & Growth Report by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Computational Pathology Market Size Analysis

Global Computational Pathology Market Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Disease Diagnosis
  1. By Value
3. Drug Discovery & Development
  1. By Value
4. Academic Research
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
  2. Deep Learning
    1. Deep Learning By Value
  3. Supervised
    1. Supervised By Value
  4. Unsupervised
    1. Unsupervised By Value
  5. Others
    1. Others By Value
3. Natural Language Processing (NLP) Models
  1. By Value
4. Computer Vision
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals and Diagnostic Labs
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Academic and Research Institutes
  1. By Value
5. Other
  1. By Value

North America Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Disease Diagnosis
  1. By Value
3. Drug Discovery & Development
  1. By Value
4. Academic Research
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
  2. Deep Learning
    1. Deep Learning By Value
  3. Supervised
    1. Supervised By Value
  4. Unsupervised
    1. Unsupervised By Value
  5. Others
    1. Others By Value
3. Natural Language Processing (NLP) Models
  1. By Value
4. Computer Vision
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals and Diagnostic Labs
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Academic and Research Institutes
  1. By Value
5. Other
  1. By Value
U.S.
1. By Component
  1. Introduction
    1. Component By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Disease Diagnosis
    1. By Value
  3. Drug Discovery & Development
    1. By Value
  4. Academic Research
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Machine Learning (ML)
    1. By Value
    2. Deep Learning
      1. Deep Learning By Value
    3. Supervised
      1. Supervised By Value
    4. Unsupervised
      1. Unsupervised By Value
    5. Others
      1. Others By Value
  3. Natural Language Processing (NLP) Models
    1. By Value
  4. Computer Vision
    1. By Value
  5. Others
    1. By Value
4. By End-use
  1. Introduction
    1. End-use By Value
  2. Hospitals and Diagnostic Labs
    1. By Value
  3. Biotechnology and Pharmaceutical Companies
    1. By Value
  4. Academic and Research Institutes
    1. By Value
  5. Other
    1. By Value
Canada

Europe Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Disease Diagnosis
  1. By Value
3. Drug Discovery & Development
  1. By Value
4. Academic Research
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
  2. Deep Learning
    1. Deep Learning By Value
  3. Supervised
    1. Supervised By Value
  4. Unsupervised
    1. Unsupervised By Value
  5. Others
    1. Others By Value
3. Natural Language Processing (NLP) Models
  1. By Value
4. Computer Vision
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals and Diagnostic Labs
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Academic and Research Institutes
  1. By Value
5. Other
  1. By Value
U.K.
1. By Component
  1. Introduction
    1. Component By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Disease Diagnosis
    1. By Value
  3. Drug Discovery & Development
    1. By Value
  4. Academic Research
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Machine Learning (ML)
    1. By Value
    2. Deep Learning
      1. Deep Learning By Value
    3. Supervised
      1. Supervised By Value
    4. Unsupervised
      1. Unsupervised By Value
    5. Others
      1. Others By Value
  3. Natural Language Processing (NLP) Models
    1. By Value
  4. Computer Vision
    1. By Value
  5. Others
    1. By Value
4. By End-use
  1. Introduction
    1. End-use By Value
  2. Hospitals and Diagnostic Labs
    1. By Value
  3. Biotechnology and Pharmaceutical Companies
    1. By Value
  4. Academic and Research Institutes
    1. By Value
  5. Other
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Disease Diagnosis
  1. By Value
3. Drug Discovery & Development
  1. By Value
4. Academic Research
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
  2. Deep Learning
    1. Deep Learning By Value
  3. Supervised
    1. Supervised By Value
  4. Unsupervised
    1. Unsupervised By Value
  5. Others
    1. Others By Value
3. Natural Language Processing (NLP) Models
  1. By Value
4. Computer Vision
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals and Diagnostic Labs
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Academic and Research Institutes
  1. By Value
5. Other
  1. By Value
China
1. By Component
  1. Introduction
    1. Component By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Disease Diagnosis
    1. By Value
  3. Drug Discovery & Development
    1. By Value
  4. Academic Research
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Machine Learning (ML)
    1. By Value
    2. Deep Learning
      1. Deep Learning By Value
    3. Supervised
      1. Supervised By Value
    4. Unsupervised
      1. Unsupervised By Value
    5. Others
      1. Others By Value
  3. Natural Language Processing (NLP) Models
    1. By Value
  4. Computer Vision
    1. By Value
  5. Others
    1. By Value
4. By End-use
  1. Introduction
    1. End-use By Value
  2. Hospitals and Diagnostic Labs
    1. By Value
  3. Biotechnology and Pharmaceutical Companies
    1. By Value
  4. Academic and Research Institutes
    1. By Value
  5. Other
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Disease Diagnosis
  1. By Value
3. Drug Discovery & Development
  1. By Value
4. Academic Research
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
  2. Deep Learning
    1. Deep Learning By Value
  3. Supervised
    1. Supervised By Value
  4. Unsupervised
    1. Unsupervised By Value
  5. Others
    1. Others By Value
3. Natural Language Processing (NLP) Models
  1. By Value
4. Computer Vision
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals and Diagnostic Labs
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Academic and Research Institutes
  1. By Value
5. Other
  1. By Value
UAE
1. By Component
  1. Introduction
    1. Component By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Disease Diagnosis
    1. By Value
  3. Drug Discovery & Development
    1. By Value
  4. Academic Research
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Machine Learning (ML)
    1. By Value
    2. Deep Learning
      1. Deep Learning By Value
    3. Supervised
      1. Supervised By Value
    4. Unsupervised
      1. Unsupervised By Value
    5. Others
      1. Others By Value
  3. Natural Language Processing (NLP) Models
    1. By Value
  4. Computer Vision
    1. By Value
  5. Others
    1. By Value
4. By End-use
  1. Introduction
    1. End-use By Value
  2. Hospitals and Diagnostic Labs
    1. By Value
  3. Biotechnology and Pharmaceutical Companies
    1. By Value
  4. Academic and Research Institutes
    1. By Value
  5. Other
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Disease Diagnosis
  1. By Value
3. Drug Discovery & Development
  1. By Value
4. Academic Research
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Machine Learning (ML)
  1. By Value
  2. Deep Learning
    1. Deep Learning By Value
  3. Supervised
    1. Supervised By Value
  4. Unsupervised
    1. Unsupervised By Value
  5. Others
    1. Others By Value
3. Natural Language Processing (NLP) Models
  1. By Value
4. Computer Vision
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals and Diagnostic Labs
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Academic and Research Institutes
  1. By Value
5. Other
  1. By Value
Brazil
1. By Component
  1. Introduction
    1. Component By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Disease Diagnosis
    1. By Value
  3. Drug Discovery & Development
    1. By Value
  4. Academic Research
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Machine Learning (ML)
    1. By Value
    2. Deep Learning
      1. Deep Learning By Value
    3. Supervised
      1. Supervised By Value
    4. Unsupervised
      1. Unsupervised By Value
    5. Others
      1. Others By Value
  3. Natural Language Processing (NLP) Models
    1. By Value
  4. Computer Vision
    1. By Value
  5. Others
    1. By Value
4. By End-use
  1. Introduction
    1. End-use By Value
  2. Hospitals and Diagnostic Labs
    1. By Value
  3. Biotechnology and Pharmaceutical Companies
    1. By Value
  4. Academic and Research Institutes
    1. By Value
  5. Other
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Computational Pathology Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Leica Biosystems Nussloch GmbH (subsidiary of Danaher)
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Hamamatsu Photonics K.K.
Koninklijke Philips N.V.
Olympus Corporation
Hoffmann-La Roche Ltd.
Aiforia/ Aiforia Technologies PLC
Epredia (3DHISTECH Ltd.)
Visiopharm A/S
Proscia Inc.
Mindpeak GmbH
Akoya Biosciences, Inc. (a Quanterix company)
Paige AI, Inc.
CellaVision
aetherAI
Qritive
IBEX
Nucleai, Inc.
Others

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment